Dudediligence.

Incannex Healthcare Inc

IXHLNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$74,000Sep ’24$12,000Dec ’24$0.00Jun ’25
Net income, by quarter
−$5.4MSep ’24−$5.9MDec ’24−$4.0MMar ’25−$31.6MJun ’25−$6.4MSep ’25−$6.5MDec ’25−$3.9MMar ’26−$2.5MJun ’26
Fiscal years, by the month each ended
LineJun 2022Jun 2023Jun 2024Jun 2025Jun 2026
Revenuenone on filenone on file$12,000$86,000$0.00
Operating incomenone on file−$49.7M−$30.0M−$23.8M−$23.0M
Net incomenone on file−$48.8M−$18.5M−$46.9M−$19.3M
Operating cash flownone on file−$10.7M−$15.8M−$12.5M−$12.9M
Free cash flownone on file−$11.1M−$16.1M−$12.5M−$12.9M
Cash$25.8M$22.1M$5.9M$15.0M$67.7M
Shares outstandingnone on file15.9M17.6M194.4M12.5M